Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model

By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]